Basic Study
Copyright ©The Author(s) 2022.
Artif Intell Cancer. Apr 28, 2022; 3(2): 27-41
Published online Apr 28, 2022. doi: 10.35713/aic.v3.i2.27
Table 1 Possible comparisons to be made during the unsupervised (i.e., we do not rely on the type of disease) global analysis of patients following the considered three different strategies
Strategy
Comparison
Strategy 1 (classic)1 vs (2,3,4)
2 vs (3,4)
3 vs 4
Strategy 2 (1&1)1 vs 2; 1 vs 3; 1 vs 4
2 vs 1; 2 vs 3; 2 vs 4
3 vs 1; 3 vs 2; 3 vs 4
4 vs 1; 4 vs 2; 4 vs 3
Strategy 3 (pairwise)1 vs (2,3,4)
2 vs (1,3,4)
3 vs (1,2,4)
4 vs (1,2,3)